The first day of Hepatitis Awareness Month coincided with the Pennsylvania Viral Hepatitis Elimination Planning Stakeholder Meeting, convened by the Pennsylvania Department of Health in Harrisburg. We heard from our partners at the Hepatitis B Foundation and Hep B United, Prevention Point, HHS, the CDC, and others from across the Read more…
Although 124 countries now have national plans for viral hepatitis elimination, 42% of plans have no domestic funding. The United States lags behind in this estimation of the year countries will achieve the World Health Organization elimination target. From Infohep: Most countries will struggle to eliminate hepatitis C by 2030 Read more…
The National Viral Hepatitis Roundtable (NVHR) will be hosting a hepatitis C (HCV) patient summit July 29 and 30, 2019. The summit, NVHR’s first national patient gathering, will bring together 100 patients cured of or currently living with HCV with an emphasis on those who have not had experience engaging Read more…
The state of Washington said Friday it has selected AbbVie to provide hepatitis C medication through an unconventional subscription payment program that seeks to expand patient access while containing drug costs. The contract is part of the state’s plan to eliminate the common viral infection by 2030. “Last year, I committed Washington to Read more…
Tuesday, May 7 at 3:00pm ET This NNLCC webinar will provide a national perspective of how the hepatitis C virus (HCV) and opioid use disorder epidemics are connected and what health centers can do to address them. We will hear from Lauren Canary from the CDC about expansion of medication-assisted Read more…
HIV-positive men living in New York City who clear hepatitis C virus (HCV), whether spontaneously or through treatment, are reinfected with hep C at a high rate that is comparable to that of their European counterparts. Previous studies conducted among HIV-positive MSM in Europe have found that those treated for Read more…
Friday, April 19, 2019 8:30am – 1:00pm Anal Cancer is a growing concern for people living with HIV. Join us for our second symposium discussing the best practices around addressing our anal health, the screening, and treatment of anal dysplasia, and anal cancer for men and women living with HIV. Read more…
Background Hepatitis C virus (HCV) testing in persons born from 1945 to 1965 has had limited adoption despite guidelines, particularly among racial/ethnic minorities and socioeconomically disadvantaged patients, who have a higher prevalence of disease burden. We examined the effectiveness of a multifaceted intervention to improve HCV screening in a large Read more…
In the late 1980s and early 1990s, cities struggling with the AIDS crisis began considering a then-radical idea: give drug users sterile needles and syringes so they wouldn’t spread HIV, the virus that causes AIDS. Underlying the idea was the acceptance that some drug use was inevitable and a belief Read more…
The opioid epidemic now brings one more worry for public health professionals in the city and at least one suburban county, as the number of new HIV diagnoses — which had been declining — has substantially increased among those who inject drugs. “There is a new epidemic among people who Read more…